Claims for Patent: 10,413,627

✉ Email this page to a colleague

Summary for Patent: 10,413,627

Title:	Communicating scale
Abstract:	A communicating sterile scale is described suitable for automated use in animal cages. An upper module provides a weighing platform, electronics, upward facing wireless communication elements, a protecting skirt, and interface to a combined weight-bearing and electrical penetration element. A lower module provides a case, internal electronics, load cell, power source, sterile-sealed flexible complaint membrane and a combined weight bearing and electrical penetration element through the membrane. The upper and lower modules are easily separable for sterilization by immersion in a sterilizing fluid. The power source in the case may be charged through same electrical penetrating element. The membrane comprises a perimeter that is attached and sealed to the case, a penetration area penetrated by the rigid weight-bearing element, and an isolating compliance area. The skirt on upper module protects detritus from entering from below onto the membrane, while providing open-air movement. Upward facing narrow-beam communication elements provide association-free communication protocols.
Inventor(s):	Kevin Harada, Jonathan Betts-LaCroix
Assignee:	Recursion Pharmaceuticals Inc , Recursion Pharmaceuticals Inc
Application Number:	US15/396,042

Details for Patent 10,413,627

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Amphastar Pharmaceuticals, Inc.	AMPHADASE	hyaluronidase	Injection	021665	October 26, 2004	⤷ Start Trial	2036-12-30
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 10,413,627

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
United States of America	9671276	⤷ Start Trial
United States of America	2017108369	⤷ Start Trial
United States of America	2017108368	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.